Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food Labeling; Notification Procedures for Statements on Dietary Supplements, 69569-69570 [E6-20307]
Download as PDF
<![CDATA[
69569
Federal Register / Vol. 71, No. 231 / Friday, December 1, 2006 / Notices
Estimated Total Annual Burden
Hours: 864.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comments
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Information Services,
370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. E-mail:
infocollection.acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: November 28, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06–9487 Filed 11–30–06; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: National Directory of New
Hires.
OMB No.: 0970–0166.
Description: Public Law 104–193, the
‘‘Personal Responsibility and Work
Opportunity Reconciliation Act of
1996,’’ requires the Office of Child
Support Enforcement (OCSE) to operate
a National Directory of New Hires
(NDNH) to improve the ability of State
child support enforcement agencies to
locate noncustodial parents and collect
child support across State lines. The law
requires employers to report newly
hired employees to States. States are
then required to periodically transmit
new hire data received from employers
to the NDNH, and to transmit wage and
unemployment compensation claims
data to the NDNH on a quarterly basis.
Federal agencies are required to report
new hires and quarterly wage data
directly to the NDNH. All data is
transmitted to the NDNH electronically.
Respondents: Employers, State Child
Support Enforcement Agencies, State
Workforce Agencies, Federal Agencies.
ANNUAL BURDEN ESTIMATES:
Number of
respondents
Instrument
rmajette on PROD1PC67 with NOTICES1
New Hire: Employers Reporting Manually .....................................................
New Hire: Employers Reporting Electronically ..............................................
New Hire: States ............................................................................................
Quarterly Wage & Unemployment Compensation ........................................
Multistate Employers’ Notification Form ........................................................
Estimated Total Annual Burden
Hours: 760,828.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
VerDate Aug<31>2005
13:50 Nov 30, 2006
Jkt 211001
5,166,000
1,134,000
54
54
2,808
Number of
responses per
respondent
Average burden
hours per
response
3.484
33.272
83.333
8
1
.025
.00028
66.7
.033
.050
Total burden
hours
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: November 28, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06–9488 Filed 11–30–06; 8:45 am]
ACTION:
449,959
10,565
300,150
14
140
BILLING CODE 4184–01–M
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Food and Drug Administration
[Docket No. 2006N–0277]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Food Labeling;
Notification Procedures for Statements
on Dietary Supplements
AGENCY:
Food and Drug Administration,
HHS.
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by January 2,
2007.
E:\FR\FM\01DEN1.SGM
01DEN1
69570
Federal Register / Vol. 71, No. 231 / Friday, December 1, 2006 / Notices
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
ADDRESSES:
Food Labeling; Notification Procedures
for Statements on Dietary
Supplements—(OMB Control Number
0910–0331)—Extension
Section 403(r)(6) of the Federal Food,
Drug, and Cosmetic Act (the act) (21
U.S.C 343(r)(6)) requires that FDA be
notified by manufacturers, packers, and
distributors of dietary supplements that
they are marketing a dietary supplement
product that bears on its label or in its
labeling a statement provided for in
section 403(r)(6) of the act. Section
403(r)(6) of the act requires that FDA be
notified, with a submission about such
statements, no later than 30 days after
the first marketing of the dietary
supplement. Information that is
required in the submission includes the
following: (1) The name and address of
the manufacturer, packer, or distributor
of the dietary supplement product; (2)
the text of the statement that is being
made; (3) the name of the dietary
ingredient or supplement that is the
subject of the statement; (4) the name of
the dietary supplement (including the
brand name); and (5) a signature of a
responsible individual who can certify
the accuracy of the information
presented, and who must certify that the
information contained in the notice is
complete and accurate, and that the
notifying firm has substantiation that
the statement is truthful and not
misleading.
FDA established § 101.93 (21 CFR
101.93) as the procedural regulation for
this program. Section 101.93 provides
details of the procedures associated
with the submission and identifies the
information that must be included in
order to meet the requirements of
section 403 of the act.
Description of Respondents:
Businesses or other for-profit
organizations.
In the Federal Register of July 24,
2006 (71 FR 41818), FDA published a
60-day notice requesting public
comment on the information collection
provisions. No comments were received
before the comment period closed.
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
21 CFR Section
No. of
respondents
101.93
1There
Annual frequency
per response
2,500
1
Hours per response
2,500
Total hours
.75
1,875
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA believes that there will be
minimal burden on the industry to
generate information to meet the
requirements of section 403 of the act in
submitting information regarding
section 403(r)(6) of the act statements on
labels or in labeling of dietary
supplements. FDA is requesting only
information that is immediately
available to the manufacturer, packer, or
distributor of the dietary supplement
that bears such a statement on its label
or in its labeling. This estimate is based
on the average number of notification
submissions received by FDA in the
preceding 12 months.
Dated: November 21, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–20307 Filed 12–01–06; 8:45 am]
BILLING CODE 4160–01–S
rmajette on PROD1PC67 with NOTICES1
Total annual responses
VerDate Aug<31>2005
13:50 Nov 30, 2006
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Equal Employment Opportunity Staff
(GFJ1)
Indian Health Service
(1) Advises the Area Director and
other key management officials in the
execution of their IHS responsibilities;
(2) provides program direction and
leadership for the Area EEO program
and procedures; and (3) ensures the
elimination of discrimination practices
in employment, promotion, training,
treatment of applicants, and employees,
because of race, color, religion, national
origin, sex, age, and handicapping
conditions.
Navajo Area Indian Health Service
(GFJ); Organization, Functions, and
Delegations of Authority
Office of the Area Director (GFJ1)
(1) Plans, develops and directs the
Area Program within the framework of
Indian Health Service (IHS) policy in
pursuit of the IHS mission; (2) delivers
and ensures the delivery of high quality
comprehensive health services; (3)
coordinates the IHS activities and
resources internally and externally with
those of other governmental and
nongovernmental programs; (4)
promotes optimum utilization of health
care services through management and
delivery of services to American Indians
and Alaska Natives; (5) encourages the
full application of the principles of
Indian preference and Equal
Employment Opportunity (EEO); and (6)
provides Indian Tribes and other Indian
community groups with optional ways
of participating in the Indian Health
programs including an opportunity to
participate in developing the mission,
values and goals for the Navajo Area
Indian Health Service (NAIHS).
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Office of Administration and
Management (GFJ2)
(1) Plans, directs, and coordinates
NAIHS activities in the areas of policy,
internal controls reviews, financial
management, personnel management,
third-party reimbursements; contract
health services (CHS) funds; contracts
management, procurement, personal
property accountability/management,
and administrative services; (2) serves
as the Navajo Area principal advisor on
all Area organization and management
policy activities; and (3) provides
guidance and assistance to service units
in the overall development, planning
and implementation of administrative
functions.
E:\FR\FM\01DEN1.SGM
01DEN1
]]>Agencies
[Federal Register Volume 71, Number 231 (Friday, December 1, 2006)]
[Notices]
[Pages 69569-69570]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20307]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N-0277]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Food Labeling;
Notification Procedures for Statements on Dietary Supplements
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by January
2, 2007.
[[Page 69570]]
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-6974.
FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief
Information Officer (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-4659.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Food Labeling; Notification Procedures for Statements on Dietary
Supplements--(OMB Control Number 0910-0331)--Extension
Section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act (the
act) (21 U.S.C 343(r)(6)) requires that FDA be notified by
manufacturers, packers, and distributors of dietary supplements that
they are marketing a dietary supplement product that bears on its label
or in its labeling a statement provided for in section 403(r)(6) of the
act. Section 403(r)(6) of the act requires that FDA be notified, with a
submission about such statements, no later than 30 days after the first
marketing of the dietary supplement. Information that is required in
the submission includes the following: (1) The name and address of the
manufacturer, packer, or distributor of the dietary supplement product;
(2) the text of the statement that is being made; (3) the name of the
dietary ingredient or supplement that is the subject of the statement;
(4) the name of the dietary supplement (including the brand name); and
(5) a signature of a responsible individual who can certify the
accuracy of the information presented, and who must certify that the
information contained in the notice is complete and accurate, and that
the notifying firm has substantiation that the statement is truthful
and not misleading.
FDA established Sec. 101.93 (21 CFR 101.93) as the procedural
regulation for this program. Section 101.93 provides details of the
procedures associated with the submission and identifies the
information that must be included in order to meet the requirements of
section 403 of the act.
Description of Respondents: Businesses or other for-profit
organizations.
In the Federal Register of July 24, 2006 (71 FR 41818), FDA
published a 60-day notice requesting public comment on the information
collection provisions. No comments were received before the comment
period closed.
Table 1.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual frequency
21 CFR Section respondents per response Total annual responses Hours per response Total hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
101.93 2,500 1 2,500 .75 1,875
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA believes that there will be minimal burden on the industry to
generate information to meet the requirements of section 403 of the act
in submitting information regarding section 403(r)(6) of the act
statements on labels or in labeling of dietary supplements. FDA is
requesting only information that is immediately available to the
manufacturer, packer, or distributor of the dietary supplement that
bears such a statement on its label or in its labeling. This estimate
is based on the average number of notification submissions received by
FDA in the preceding 12 months.
Dated: November 21, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-20307 Filed 12-01-06; 8:45 am]
BILLING CODE 4160-01-S
